Meeting
2016 ASCO Annual Meeting
Sandwich-like gemcitabine, dexamethasone, and cisplatin(GDP) chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, upper aerodigestive tract natural killer/T-cell lymphoma.
Authors
Shu Tian
Department of Radiation Oncology, Eye Ear Nose and Throat Hospital, Fudan University, Shanghai, China
Shu Tian , Li fen Zou , Wei fang Wang , Wei Yuan , Sheng zi Wang , Hao Ding
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Non-Hodgkin Lymphoma
Citation
J Clin Oncol 34, 2016 (suppl; abstr 7561)
DOI
10.1200/JCO.2016.34.15_suppl.7561
Abstract #
7561
Poster Bd #
117
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
The efficacy of trimodal chemoradiotherapy with gemcitabine and cisplatin as a bladder-preserving strategy for the treatment of muscle invasive bladder cancer: A single-arm prospective study.
First Author: Hiroaki Matsumoto
Poster
2013 ASCO Annual Meeting
Radiotherapy for nasal cavity and Waldeyer ring natural killer/T-cell lymphoma: Analysis in 131 patients.
First Author: Yuan Zhu
Poster
2023 ASCO Annual Meeting
Phase II trial of XmAb20717 (vudalimab) in patients with advanced biliary tract cancers.
First Author: William Joseph Chapin
Poster
2023 ASCO Genitourinary Cancers Symposium
Early efficacy results from atezolizumab (ATZ) with split doses of cisplatin plus gemcitabine in patients with locally advanced or metastatic urothelial carcinoma (SOGUG-AUREA).
First Author: Guillermo de Velasco